tiprankstipranks
Trending News
More News >
Insight Molecular Diagnostics (IMDX)
NASDAQ:IMDX
US Market

Insight Molecular Diagnostics (IMDX) Income Statement

Compare
429 Followers

Insight Molecular Diagnostics Income Statement

Last quarter (Q3 2025), Insight Molecular Diagnostics's total revenue was $260.00K, an increase of 126.09% from the same quarter last year. In Q3, Insight Molecular Diagnostics's net income was $-10.85M. See Insight Molecular Diagnostics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.88M$ 1.50M$ 958.00K$ 2.20M$ 1.22M
Gross Profit
$ 740.00K$ 413.00K$ -18.00K$ 1.42M$ -639.00K
Operating Expenses
$ 61.78M$ 25.55M$ 17.98M$ 55.15M$ 29.07M
Depreciation and Amortization
$ 1.56M$ 1.68M$ 5.22M$ 4.21M$ 394.00K
EBITDA
$ -59.02M$ -23.12M$ -13.31M$ -48.46M$ -30.54M
Operating Income
$ -61.04M$ -25.14M$ -18.00M$ -53.73M$ -29.71M
Other Income/Expenses
$ 378.00K$ 281.00K$ -615.00K$ 854.00K$ -1.48M
Pretax Income
$ -60.66M$ -24.86M$ -18.61M$ -52.87M$ -31.19M
Net Income
$ -60.66M$ -27.78M$ -72.90M$ -64.10M$ -29.93M
Per Share Metrics
Basic EPS
$ -4.66$ -3.75$ -20.00$ -14.40$ -9.14
Diluted EPS
$ -4.66$ -3.75$ -20.00$ -14.40$ -9.14
Weighted Average Shares Outstanding
13.07M 7.65M 5.54M 4.45M 3.27M
Weighted Average Shares Outstanding (Diluted)
13.07M 7.65M 5.54M 4.45M 3.27M
Currency in USD

Insight Molecular Diagnostics Earnings and Revenue History